Julie Méthot

Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial

Daniel Gaudet, Julie Méthot, S. Déry et al. · Gene Therapy · 2012 · 399 citations · Full text

Medicine, Molecular Medicine, Pharmacology +14

Immune Responses to Intramuscular Administration of Alipogene Tiparvovec (AAV1-LPL ^S447X ) in a Phase II Clinical Trial of Lipoprotein Lipase Deficiency Gene Therapy

Valérie Ferreira, Jaap Twisk, Karin L. Kwikkers et al. · Human Gene Therapy · 2013 · 130 citations

Medicine, Immunology, Molecular Medicine +13

Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis

Daniel Gaudet, Erik S.G. Stroes, Julie Méthot et al. · Human Gene Therapy · 2016 · 99 citations · Full text

Medicine, Internal Medicine, Translational Sciences +16

Etiology and risk of lactescent plasma and severe hypertriglyceridemia

Karine Tremblay, Julie Méthot, Diane Brisson et al. · Journal of clinical lipidology · 2010 · 63 citations

Medicine, Endocrinology, Nutritional Sciences +8

Influence of the menstrual cycle on the timing of acute coronary events in premenopausal women

Bettina A. Hamelin, Julie Méthot, Marie Arsenault et al. · The American Journal of Medicine · 2003 · 54 citations · Full text

Medicine, Cardiology, Gynecology +16